Skip to main content
NCBI home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1987 Jun 1;165(6):1609–1623. doi: 10.1084/jem.165.6.1609

Differentiation-linked secretion of urokinase and tissue plasminogen activator by normal human hemopoietic cells

PMCID: PMC2188366  PMID: 3108448

Abstract

Previous studies have shown that the response of patients with acute myeloid leukemia to induction chemotherapy can be predicted by the species of plasminogen activator that their cells secrete. Patients whose cells secreted tissue plasminogen activator (tPA) only failed to respond to combination chemotherapy. Individuals whose leukemic cells display features of the early progenitor phenotype also respond poorly to therapy. This suggested that the two species of plasminogen activator secreted by leukemic cells might be produced by normal cells at distinct stages of differentiation. These results indicate that the secretion of the two enzyme types is a differentiation-linked property of normal cells with tPA being produced by granulocyte/macrophage progenitors and urokinase by more differentiated cells and by mature neutrophils and macrophages.

Full Text

The Full Text of this article is available as a PDF (1.0 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aye M. T., Niho Y., Till J. E., McCulloch E. A. Studies of leukemic cell populations in culture. Blood. 1974 Aug;44(2):205–219. [PubMed] [Google Scholar]
  2. Bergmann S. R., Fox K. A., Ter-Pogossian M. M., Sobel B. E., Collen D. Clot-selective coronary thrombolysis with tissue-type plasminogen activator. Science. 1983 Jun 10;220(4602):1181–1183. doi: 10.1126/science.6602378. [DOI] [PubMed] [Google Scholar]
  3. Bykowska K., Levin E. G., Rijken D. C., Loskutoff D. J., Collen D. Characterization of a plasminogen activator secreted by cultured bovine aortic endothelial cells. Biochim Biophys Acta. 1982 Apr 21;703(1):113–115. doi: 10.1016/0167-4838(82)90018-8. [DOI] [PubMed] [Google Scholar]
  4. Collen D., Stassen J. M., Verstraete M. Thrombolysis with human extrinsic (tissue-type) plasminogen activator in rabbits with experimental jugular vein thrombosis. Effect of molecular form and dose of activator, age of the thrombus, and route of administration. J Clin Invest. 1983 Feb;71(2):368–376. doi: 10.1172/JCI110778. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Fauser A. A., Messner H. A. Granuloerythropoietic colonies in human bone marrow, peripheral blood, and cord blood. Blood. 1978 Dec;52(6):1243–1248. [PubMed] [Google Scholar]
  6. Francis G. E. A bioassay system for two types of colony stimulating factor in human serum. Exp Hematol. 1980 Jul;8(6):749–762. [PubMed] [Google Scholar]
  7. Francis G. E., Berney J. J., Bodger M. P., Bol S. J., Wing M. A., Hoffbrand A. V. Clone size potential and sensitivity to colony-stimulating activity: differentiation-linked properties of granulocyte-macrophage progenitor cells. Stem Cells. 1981;1(2):124–139. [PubMed] [Google Scholar]
  8. Francis G. E., Berney J. J., Chipping P. M., Hoffbrand A. V. Stimulation of human haemopoietic cells by colony stimulating factors: sensitivity of leukaemia cells. Br J Haematol. 1979 Apr;41(4):545–562. doi: 10.1111/j.1365-2141.1979.tb05892.x. [DOI] [PubMed] [Google Scholar]
  9. Francis G. E., Berney J. J., Wing M. A., Tuma G. A., Hoffbrand A. V. Relative and absolute deficiency of bone marrow endogenous colony stimulating activity in acute myeloid leukemia: relation to response to chemotherapy. Leuk Res. 1982;6(2):165–173. doi: 10.1016/0145-2126(82)90022-4. [DOI] [PubMed] [Google Scholar]
  10. Francis G. E., Bol S. J., Berney J. J. Effect of feeder layer activity on buoyant density distributions of granulocyte-macrophage colony forming cells. Scand J Haematol. 1982 Jan;28(1):39–44. doi: 10.1111/j.1600-0609.1982.tb02118.x. [DOI] [PubMed] [Google Scholar]
  11. Francis G. E. Response to therapy in acute myeloid leukaemia: an explanation of two unrelated findings. Med Hypotheses. 1979 Sep;5(9):999–1006. doi: 10.1016/0306-9877(79)90048-3. [DOI] [PubMed] [Google Scholar]
  12. Francis G. E., Tuma G. A., Berney J. J., Hoffbrand A. V. Sensitivity of acute myeloid leukaemia cells to colony stimulating activity: relation to response to chemotherapy. Br J Haematol. 1981 Oct;49(2):259–267. doi: 10.1111/j.1365-2141.1981.tb07222.x. [DOI] [PubMed] [Google Scholar]
  13. Francis G. E., Wing M. A., Berney J. J., Guimaraes J. E. CFUGEMM, CFUGM, CFUMK: analysis by equilibrium density centrifugation. Exp Hematol. 1983 Jul;11(6):481–489. [PubMed] [Google Scholar]
  14. Goldfarb R. H., Quigley J. P. Synergistic effect of tumor virus transformation and tumor promoter treatment on the production of plasminogen activator by chick embryo fibroblasts. Cancer Res. 1978 Dec;38(12):4601–4609. [PubMed] [Google Scholar]
  15. Granelli-Piperno A., Vassalli J. D., Reich E. Secretion of plasminogen activator by human polymorphonuclear leukocytes. Modulation by glucocorticoids and other effectors. J Exp Med. 1977 Dec 1;146(6):1693–1706. doi: 10.1084/jem.146.6.1693. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Guimaraes J. E., Berney J. J., Francis G. E., Hoffbrand A. V. The identification of mixed granulocytic-erythrocytic colonies in vitro. Exp Hematol. 1984 Aug;12(7):535–538. [PubMed] [Google Scholar]
  17. Guimaraes J. E., Francis G. E., Bol S. J., Berney J. J., Hoffbrand A. V. Differentiation restriction in the neutrophil-granulocyte, macrophage, eosinophil-granulocyte pathway: analysis by equilibrium density centrifugation. Leuk Res. 1982;6(6):791–800. doi: 10.1016/0145-2126(82)90061-3. [DOI] [PubMed] [Google Scholar]
  18. Mak T. W., Rutledge G., Sutherland D. J. Androgen-dependent fibrinolytic activity in a murine mammary carcinoma (Shionogi SC-115 cells) in vitro. Cell. 1976 Feb;7(2):223–226. doi: 10.1016/0092-8674(76)90021-0. [DOI] [PubMed] [Google Scholar]
  19. Markus G., Takita H., Camiolo S. M., Corasanti J. G., Evers J. L., Hobika G. H. Content and characterization of plasminogen activators in human lung tumors and normal lung tissue. Cancer Res. 1980 Mar;40(3):841–848. [PubMed] [Google Scholar]
  20. McCulloch E. A., Curtis J. E., Messner H. A., Senn J. S., Germanson T. P. The contribution of blast cell properties to outcome variation in acute myeloblastic leukemia (AML). Blood. 1982 Mar;59(3):601–608. [PubMed] [Google Scholar]
  21. Moore M. A., Spitzer G., Williams N., Metcalf D., Buckley J. Agar culture studies in 127 cases of untreated acute leukemia: the prognostic value of reclassification of leukemia according to in vitro growth characteristics. Blood. 1974 Jul;44(1):1–18. [PubMed] [Google Scholar]
  22. Ossowski L., Biegel D., Reich E. Mammary plasminogen activator: correlation with involution, hormonal modulation and comparison between normal and neoplastic tissue. Cell. 1979 Apr;16(4):929–940. doi: 10.1016/0092-8674(79)90108-9. [DOI] [PubMed] [Google Scholar]
  23. Pike B. L., Robinson W. A. Human bone marrow colony growth in agar-gel. J Cell Physiol. 1970 Aug;76(1):77–84. doi: 10.1002/jcp.1040760111. [DOI] [PubMed] [Google Scholar]
  24. Strickland S., Beers W. H. Studies on the role of plasminogen activator in ovulation. In vitro response of granulosa cells to gonadotropins, cyclic nucleotides, and prostaglandins. J Biol Chem. 1976 Sep 25;251(18):5694–5702. [PubMed] [Google Scholar]
  25. Tucker W. S., Kirsch W. M., Martinez-Hernandez A., Fink L. M. In vitro plasminogen activator activity in human brain tumors. Cancer Res. 1978 Feb;38(2):297–302. [PubMed] [Google Scholar]
  26. Vassalli J. D., Hamilton J., Reich E. Macrophage plasminogen activator: induction by concanavalin A and phorbol myristate acetate. Cell. 1977 Jul;11(3):695–705. doi: 10.1016/0092-8674(77)90086-1. [DOI] [PubMed] [Google Scholar]
  27. Vetterlein D., Young P. L., Bell T. E., Roblin R. Immunological characterization of multiple weight forms of human cell plasminogen activators. J Biol Chem. 1979 Feb 10;254(3):575–578. [PubMed] [Google Scholar]
  28. Wigler M., Weinstein I. B. Tumour promotor induces plasminogen activator. Nature. 1976 Jan 22;259(5540):232–233. doi: 10.1038/259232a0. [DOI] [PubMed] [Google Scholar]
  29. Wilson E. L., Becker M. L., Hoal E. G., Dowdle E. B. Molecular species of plasminogen activators secreted by normal and neoplastic human cells. Cancer Res. 1980 Mar;40(3):933–938. [PubMed] [Google Scholar]
  30. Wilson E. L., Dowdle E. Secretion of plasminogen activator by normal, reactive and neoplastic human tissues cultured in vitro. Int J Cancer. 1978 Oct 15;22(4):390–399. doi: 10.1002/ijc.2910220405. [DOI] [PubMed] [Google Scholar]
  31. Wilson E. L., Jacobs P., Dowdle E. B. The secretion of plasminogen activators by human myeloid leukemic cells in vitro. Blood. 1983 Mar;61(3):568–574. [PubMed] [Google Scholar]
  32. Wilson E. L., Reich E. Plasminogen activator in chick fibroblasts: induction of synthesis by retinoic acid; synergism with viral transformation and phorbol ester. Cell. 1978 Oct;15(2):385–392. doi: 10.1016/0092-8674(78)90007-7. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES